Beta-cyclodextrin, 2-hydroxyethyl ethers is a modified cyclodextrin derivative used as a pharmaceutical excipient. Its primary significance lies in its ability to improve the aqueous solubility of poorly soluble drugs, facilitating their formulation and manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing .beta.-Cyclodextrin, 2-hydroxyethyl ethers?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Melarsomine
pharmaceutical raw material
6-OH Alosetron
pharmaceutical raw material
Romidepsin
pharmaceutical raw material
Dotinurad
pharmaceutical raw material
Beta-Cyclodextrin hydrate
pharmaceutical raw material
Betadex
thickening and encapsulation agent
2,6-di-O-methyl-β-cyclodextrin
pharmaceutical raw material
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30S,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-37,39,41,43,45,47,49-heptakis(2-hydroxyethoxy)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38,40,42,44,46,48-heptol
PCWPQSDFNIFUPO-KCVBUHIQSA-N
C(CO[C@H]1[C@@H]([C@H]2[C@H](O[C@@H]1O[C@@H]3[C@H](O[C@@H]([C@H]([C@@H]3O)OCCO)O[C@@H]4[C@H](O[C@@H]([C@H]([C@@H]4O)OCCO)O[C@@H]5[C@H](O[C@@H]([C@H]([C@@H]5O)OCCO)O[C@@H]6[C@@H](O[C@@H]([C@H]([C@@H]6O)OCCO)O[C@@H]7[C@H](O[C@@H]([C@H]([C@@H]7O)OCCO)O[C@@H]8[C@H](O[C@H](O2)[C@H]([C@@H]8O)OCCO)CO)CO)CO)CO)CO)CO)CO)O)O
—
Sourcing .beta.-Cyclodextrin, 2-hydroxyethyl ethers?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.